In addition to A2AR antagonists, some other immunotherapeutic drugs, such as antagonists of STING, TLR, PD-1/PD-L1, and other targets, can also be delivered by this kind of smart nano systems, thereby increasing tumor accumulation and decreasing systemic toxicity. The gene discussed is STING1; the disease is neoplasm.